Marex Group’s Bausch Health BHC Stock Holding History

Marex Group’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$410K	Buy	83,181 +8,409	+11%	+$45.1K	﹤0.01%	763
2026 Q1	$404K	Buy	74,772 +44,445	+147%	+$266K	﹤0.01%	682
2025 Q4	$211K	Sell	30,327 -23,206	-43%	-$153K	﹤0.01%	833
2025 Q3	$345K	Buy	+53,533	New	+$366K	﹤0.01%	590
2023 Q2	–	Sell	-44,798	Closed	-$363K	–	238
2023 Q1	$363K	Buy	44,798 +1,630	+4%	+$13.1K	0.05%	180
2022 Q4	$271K	Buy	+43,168	New	+$302K	0.04%	206

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Marex Group's BHC Position: Q2 2026 in Review

Marex Group increased its Bausch Health (BHC) stake by 11% in Q2 2026, buying an estimated $45.1K and bringing the position to 83,181 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #763.

Marex Group first reported a position in BHC in Q4 2022 and has held it in 6 quarters since. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

Marex Group held 83,181 shares of Bausch Health worth $410K as of Q2 2026.
Marex Group bought 8,409 Bausch Health shares in Q2 2026, an estimated $45.1K.
Bausch Health made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #763 holding.
Marex Group first reported a position in Bausch Health in Q4 2022 and has held it in 6 quarters since.
222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.